Fly News Breaks for March 6, 2015
SSH
Mar 6, 2015 | 10:31 EDT
Piper Jaffray believes the Counter HF trial enrollment halt will result in a time delay of 2-3 months and not meaningfully change Sunshine Heart's long term opportunity. Piper thinks management is being "appropriately cautious" by halting enrollment and says its thesis on the stock remains unchanged. It reiterates an Overweight rating on Sunshine Heart with an $11 price target.
News For SSH From the Last 2 Days
There are no results for your query SSH